Viavi Solutions Inc. (VIAV) Earnings Call Transcript
November 4, 2026
Earnings Call Speaker Segments
Thanks, Jonathan. Good afternoon, everybody. Welcome to the Viavi Solutions earnings call for the fiscal first quarter of 2027. I'm Vibhuti Nayar, Head of Investor Relations at Viavi Solutions; joining us today are Oleg Khaykin, our President and CEO, and Ilan Daskal, our CFO. Please be aware that forward-looking statements will be part of this call, covering the company's financial performance, outlook, and longer-term growth strategy. Those statements depend on several assumptions, including sustained capital spending — especially from the data center ecosystem, service providers, and aerospace and defense customers — along with our capacity to hold or grow market share, to develop and deliver new products on schedule, to secure adequate component availability, and to operate under stable macroeconomic conditions; that list of assumptions isn't exhaustive, and further assumptions, risks, and uncertainties are covered in our SEC filings. Risks and uncertainties attach to these statements, and actual results could therefore differ materially from what we currently estimate and expect. For more information on the assumptions, risks, and uncertainties behind these forward-looking statements, please review our latest annual report on Form 10-K, which was filed with the SEC on August 13, 2026, along with our quarterly SEC filings — particularly the risk factors laid out in those documents; these forward-looking statements, which include the guidance we are giving on this call and our expectations for the end markets, revenue growth, and market expansion, hold only as of today. Viavi has no obligation to update them. Also note that, unless we say otherwise, every result we discuss on this call other than revenue is non-GAAP; in today's earnings release, we reconcile those non-GAAP results to our preliminary GAAP financials and discuss how useful they are and what their limitations are. That release, plus our supplemental earnings slides containing historical financial tables, can be found on Viavi's website at www.investor.viavisolutions.com. Lastly, today's call is being recorded, and the recording will be posted to our website by 4:30 P.M. Pacific Time this evening. With that, I'll hand things over to Ilan. Ilan?
Thanks, Vibhuti. Good afternoon, everyone. I'd now like to walk through our results for the first quarter of fiscal year 2027. Net revenue came in at $469.3 million for the quarter, topping the high end of the $450 million-$460 million range we had guided to. Sequentially, revenue rose 5.9%, and compared with a year earlier it climbed 56.9%. Operating margin for the first fiscal quarter stood at 29%, above the top of our guidance range of 26.7%-27.5%. That operating margin was 5 percentage points wider than in the prior quarter, and versus a year ago it came in 12.7 percentage points higher. Within operating margin there was a net benefit of roughly 110 basis points from a tariff refund of approximately $11 million, partly offset by the extra week of certain variable costs. EPS of $0.47 was comfortably above our guidance range of $0.40-$0.42 and rose $0.13 quarter over quarter; compared with a year earlier, EPS gained $0.32. EPS carries a net benefit of roughly $0.02 stemming from tariff refunds and from the additional week of variable expenses. Turning to our Q1 results by business segment. NSE revenue for the first fiscal quarter totaled $376.1 million, exceeding the high end of our guidance range of $360 million-$368 million. Spirent product lines contributed $52.7 million in revenue. Year over year, NSE revenue grew 74.1%, reflecting sustained strong demand for our lab and production and field products, fueled by the data center, along with the acquisition of Spirent product lines. Demand for our aerospace and defense products was also strong. NSE gross margin for the quarter was 66.2%, 310 basis points better than a year earlier, driven primarily by the tariff refunds and product mix. NSE's operating margin for the quarter reached 25.5%, compared with 8.2% in the same quarter last year. NSE operating margin came in well above our guidance range of 22.6%-23.6%, largely due to higher fall-through. OSP revenue for the first fiscal quarter was $93.2 million, also above the high end of our guidance range of $90 million-$92 million. Year over year, OSP revenue increased 12.2%, driven by strength in 3D sensing and anti-counterfeiting and other products. OSP gross margin was 57.1%, up 460 basis points year over year, primarily on higher volume and favorable product mix. OSP's operating margin was 43.2%, in line with our guidance range of 43%-43.4%. OSP operating margin rose 600 basis points compared with a year earlier. Moving on to the balance sheet and cash flow. Total cash and short-term investments at the end of Q1 were $535.3 million, versus $656.7 million in the fourth fiscal quarter of 2026. Cash flow from operating activities for the quarter was $104.7 million compared with $31 million in the same period last year, driven by higher net income and the timing of working capital. Capital expenditures came to $12 million this quarter, compared with $8.5 million a year earlier. In Q1, we bought roughly 3,949,000 of our own shares, spending approximately $150 million, at an average price of $37.98 per share. Roughly $18 million is left available under the share repurchase authorization currently in place, and a fresh $500 million buyback program has been approved by our board of directors. Organic growth, possible M&A targets, and opportunistic share repurchases will remain the priorities of our capital allocation strategy. Fully diluted shares for the quarter totaled 266.2 million, an increase from 227.9 million in the prior year and compared with 268 million in our guidance for the first fiscal quarter. Now turning to guidance for the second quarter of fiscal year 2027: we anticipate sequential revenue growth for Viavi in the second fiscal quarter, powered by sustained momentum across our key end markets. Quarter-over-quarter growth should persist through the remainder of the fiscal year, supported by tailwinds in our end markets; within NSE, second fiscal quarter revenue is expected to rise on the back of continued robust demand for lab, production, and field products, fueled by the data center ecosystem along with aerospace and defense customers. In OSP, we anticipate quarter-over-quarter revenue will decline, consistent with the seasonal pattern of softer demand for 3D sensing, anti-counterfeiting, and other products. For the second fiscal quarter of 2027, Viavi revenue is projected at $505 million to $515 million; NSE revenue for that same quarter is expected to land between $426 million and $434 million. OSP revenue should come in at $79 million to $81 million. Viavi's operating margin is forecast at 29.3%, ± 30 basis points. For NSE, the operating margin is projected at 28.1%, ± 30 basis points. OSP operating margin should be 35.7%, ± 20 basis points, while EPS is anticipated in the $0.50 to $0.52 range. Tax expense for the second quarter should be roughly $12 million, ± $500,000, owing to jurisdictional mix; other income and expenses are expected to show a net expense of about $3.5 million, and the share count should be approximately 264 million. With that, I'll hand the call to Oleg. Oleg?
Thanks, Ilan. We beat the top of our guidance range in the first quarter. Fiscal 2027 is starting well. Many of our end markets delivered strong growth, and that drove the year-over-year results. NSE revenue rose roughly 74% year-over-year in fiscal Q1, mainly on continued robust demand from data center plus aerospace and defense customers. To be more specific, the data center segment — covering high-performance semis, optical modules, NEMs, and hyperscalers — generated strong demand for lab, production, and field instruments supporting scale-up, scale-out, and scale-across applications. Beyond the traditional lab and production end markets, we broadened our TAM to include semiconductor packaging and test. As NPO and CPO technologies get adopted, we anticipate semiconductor packaging and test will turn into a major new growth area for Viavi. The September quarter was a major milestone, since we began initial shipments into that segment. Demand from data centers for our products is still very strong, and we anticipate continued robust growth in this segment in calendar 2027. Our aerospace and defense business posted yet another quarter of strong year-over-year and quarter-on-quarter growth, fueled by demand for our Positioning, Navigation and Timing products. Robust demand is also showing up for our communication and avionics products. The U.S. Army's Threat Systems Management Office recently chose our T/Rx system to build complex, realistic electromagnetic environments across newly opened Army test ranges in support of drones, counter-drones, and interceptor development. Over the next several years, this could be a sizable growth opportunity for Viavi; we anticipate strong momentum in our A&D business unit carrying into calendar 2027. The service provider business — spanning field instruments, wireless, and service enablement products — was up, fueled by seasonal demand that came in stronger than expected. Highlights included greater demand for our fiber monitoring systems supporting fiber build-outs and for our cable instruments supporting DOCSIS 4.0 and DAA cable architecture. We are also seeing early signs of a multi-year refresh cycle among service providers as they start upgrading and replacing equipment bought in 2020 through 2022. Wireless products remain the sole weak spot in the service provider segment, given the anemic spending environment. Still, we stay optimistic about the medium-term prospects for our wireless business as AI-RAN and 6G development begin to ramp up. Finally, our OSP business unit also posted strong year-over-year revenue growth, fueled by 3D sensing and anti-counterfeiting and other products. Turning to Q2, we anticipate a very strong quarter for NSE; we expect NSE revenue to rise quarter-on-quarter, fueled by strong and growing demand from data center and aerospace and defense customers. We also anticipate seasonal tailwinds from service providers. On the other hand, we expect the OSP business unit to decline quarter-on-quarter, consistent with seasonally lower demand for both anti-counterfeiting and 3D sensing products. All told, we're looking for a meaningful sequential increase this quarter, as robust NSE demand should more than compensate for an OSP quarter that's seasonally softer. In short, fiscal 2027 has begun very well for us, and we anticipate that strong momentum carrying through the back half of the fiscal year. This quarter, we expect to hit a $2 billion revenue run rate, which is ahead of what we previously anticipated. Looking forward at our diverse end markets, customer dynamics, and the expanding Viavi end market footprint, we anticipate the present growth momentum persisting over the coming several years; four major drivers, in our view, underpin our growth strategy. Number one is the data center segment's continued growth, fueled by ongoing investment in scale-up, scale-out, and scale-across applications, an expanded Viavi TAM that includes semiconductor assembly and test plus fiber manufacturing, greater fiber penetration and densification within the data center, and quicker product replacement cycles. Driver two is continued aerospace and defense growth, fueled by strong demand for our Positioning, Navigation and Timing products. Driver three is a multi-year service provider refresh cycle, and driver four, over the longer term, is a recovery in the wireless business fueled by the 6G and AI ramp. Okay? To sum up, I want to thank the Viavi team for their continued strong innovation and execution, and to thank our customers and shareholders for their continued support. With that, I'll hand it back to the operator for Q&A.
Yes, hello. Thanks for taking my questions, and congratulations, Ilan and Oleg, on the outlook toward a $2 billion run rate. Oleg, you mentioned the momentum heading into the December quarter and a few of the drivers behind it. I'm curious, when you consider that roughly 14% quarter-on-quarter guide for NSE going into the fourth quarter, could you perhaps take us through how much of that step-up comes from the traditional data center ecosystem as opposed to OSP seasonality, which I believe tends to be strong in the December quarter, and then A&D?
Yeah, I mean, I think if you really look, each of our product lines is growing as we go into the December quarter. I mean, obviously, I'd say field instruments and service enablement are gaining from seasonally stronger service provider spend. But I'd say, looking at the projected NSE growth, I'd say roughly a third comes from data center growth, roughly a third coming, actually, maybe about 40% coming from data center growth. Around a third comes from aerospace and defense, and the remainder is service provider. So, really, in the NSE business, we're seeing solid growth pretty much everywhere, anywhere from 10% to 30%, depending on which product line.
Okay. Yeah. Right, that helps. Then to follow up: Ilan mentioned that sequential growth should keep going through the fiscal year. Usually March is a weaker quarter seasonally, and I'd imagine some of those data center tailwinds carry on as you look toward calendar 2027. Oleg, you also mentioned entering the optical plane of semiconductor test, and there's been discussion of things like NPO and CPO. At a high level, could you describe the revenue opportunity in that new area of your business, who the early customers are, and whether some of that revenue is factored into the guidance for continued sequential growth through fiscal 2027? Thank you.
Sure, yes. So traditionally, in our lab and production business, you sell into contract manufacturing, mostly making fiber optic modules, pluggables, I'd say. As NPO and CPO gain penetration, we're actually opening up an entirely new market segment, which traditionally would also be called an OSAT, outsourced assembly and test. That means selling our optical test products into the probe stations, so to speak, at the foundry, and then of course the multiple insertions at final assembly and test. So for Viavi, that's a completely new market segment. We shipped the first units this quarter, and we believe this could become a sizable segment within a couple years. North of $100 million for Viavi on its own, I mean. So it's a nice growth market, and it's clearly an attractive segment, more predictable than many of our service provider segments. The other area is what we also discussed — densification of fiber and making these massive parallel connectors. Just as we're now seeing demand for our products in the semiconductor supply chain, we're also seeing a market open up with the fiber optic and connector manufacturers. So that's two new market segments we're entering on top of our traditional pluggable testing, so to speak. So that's very attractive, and it's clearly driven by market size and volume. To the extent we see more densification, more multi-core fibers, more integrated silicon photonics closer to the ASIC, that will be the principal driver of demand in those markets; as for customers, those are all the usual suspects. I think you pretty much know all the major AI processor and optical switch vendors, as well as the Ethernet switch vendors, who are the early adopters of CPO and NPO technologies.
Great. Thanks for the detail, Oleg.
Sure.
Thanks a lot for taking the question, and I appreciate the positive view on the outlook, guys. I'd like to probe a few product cycles in the data center space and get a sense of where things stand from where you sit, perhaps beginning with the 1.6T optical modules. Clearly we're at an inflection point right now, and from your vantage point selling test equipment, has most of that production capacity already been constructed for you, or does Viavi still have plenty of runway ahead when it comes to selling into the production capacity side?
Honestly, I'd describe it as still very early innings. To use a baseball comparison, we're likely in the second or third inning. The 1.6 peak probably arrives at some point in the back half of next year, I mean, as far as getting near high volume goes. Right now, 800G remains our largest shipment volume. 1.6-
Yeah.
We're really only beginning to ramp up. I can picture 800 and 1.6 running side by side for a good while. Still, the earliest point when 1.6 overtakes 800 is likely the end of next calendar year.
Understood. That's useful, thanks. Then perhaps regarding some of these new OCS products now reaching the market for optical switching, I'd imagine your fiber testers include monitoring, so there's likely some opportunity to sell into this new product cycle. How would you size that opportunity for you?
Oh, that one — I think OCS is probably, when you look at it from the test content standpoint, likely among the biggest sweet spots out there in terms of dollar content per port. So clearly, as those volumes increase, it's a very appealing segment for us.
Understood. Great; so maybe just switching direction toward the defense and aerospace side of things—any detail you can share regarding the product mix? My assumption is this is mostly, is it still led by your PNT within the drone ecosystem, or do other products play a significant part there too?
I would say it's the drone ecosystem—aerial, ground, sea, and undersea drones—with the alternative GPS to GNSS coming after that. So it's all those products for anti-spoofing and anti-jamming equipment where resilient timing and navigation systems are required. So it kind of covers retrofitting in the field system as well as the new products being launched.
Understood. Perhaps one final question, if I can fit it in regarding wireless. You mentioned that, with luck, some improvement could come there. Do you think this chance—where SpaceX is discussing establishing a new terrestrial carrier—is a genuine opening for you to sell your field gear into that, and likely lab equipment too?
Well, I mean, obviously, if anyone is going to pursue it, the equipment has to be developed, so that will generate some of our sales. But I also see it as a positive, because it brings a kind of new participant into the market. Clearly, I know just as much about it as you do when it comes to all the early statements. I think it will all contribute to 6G and AI-RAN deployment involving the non-terrestrial network elements. I think the sooner someone gets moving, it will be more of a shift in equilibrium, where things are currently kind of in a limbo state. I mean, there's R&D happening, and we're selling into that. But until things ramp up into high gear with the planned deployment, that's when you'll really see volume picking up.
Cool.
So we welcome.
Thanks for the time .
more innovation.
Yeah. Yeah. Thanks, Oleg.
Sure.
Thank you so much. Oleg, there's a great deal of curiosity out there about NPO and CPO. Could you share a bit more color on whether September actually saw any revenues from those, or if they truly begin in December, and from where you sit, is the emphasis more on NPO or on CPO? And whatever additional detail you can offer about that as a growth driver for 2027 and beyond, I believe folks would find valuable.
As I mentioned, our first milestone shipments landed in the September quarter. Picture it as one shipment worth a million dollars, merely an early start. It is picking up pace in the December quarter; that acceleration will carry on into the March quarter and onward from there. So it has begun. We made our initial shipments in September, and it has been ramping each quarter from then on. And it is mainly in support of CPO. Some designs, I think, may be NPO, but the overwhelming mix, in my view, is supporting CPO.
All right, thank you for that. Regarding the operating margin, operating income grew by a larger amount than revenue did during the quarter. So if we were to strip out the entire $11 million tariff refund, I'm calculating an incremental operating margin of roughly 70%. Would you agree with that? Because previously you've cited figures closer to the 40s, perhaps the 50s — was that too conservative, and is the actual incremental operating margin higher, simply going by what the evidence shows here?
Well, I'd say probably, with everything else held constant, you always have a leading piece and a lagging piece. I mean, at some point you do add certain OpEx costs along with some bonuses and similar items; so in the early stage, when this incremental cost comes through, an outsized portion drops to the bottom line; but also, I wouldn't put it at 70. For this particular quarter, I'd say it's likely closer to the high 50s, low 60s. Still, I believe the prudent and sound way to view it is as low to mid-50s in terms of incremental fall-through to the bottom line.
And Mike, another point: a portion of this quarter's opex reflects timing, and much the same holds for the December quarter. Typically, once you reach the March quarter, operating expenses rise just a bit.
Every one of those statutory costs.
Plus miscellaneous items and so forth; in the same way, when we're doing things like recruiting, like R&D, and so on. So timing is the whole story here, that's all.
That's a fair observation, and honestly, it's something we've highlighted over the past several quarters. There's meaningful operating leverage built into our model when revenue rises, since what really increases is volume rather than extra work content or additional headcount and similar items. And then, naturally, as you picked up on, our tax expense now sits in the single digits, and that's the second source of operating leverage, coming from our JDS Uniphase heritage, where we inherited a massive NOL. So all of that is at last coming together, and we're seeing real strength both in operations and in the operating leverage on gross margin, along with operating margin, plus the lift in net profit.
Yeah, Mike, our effective tax rate came in at 8% for this quarter, which is, I think, unusually low by our own historical standards.
Yes.
Excellent. Alright, that's great. Then I'll squeeze in one final question. What I'd say is this guidance is really impressive, particularly when you factor in the sequential decline in OSP. It's an extremely, extremely robust outlook. Considering the stock's current level and the fact that the market reaction hasn't been as favorable as I'd have anticipated, it seems fairly obvious that credit worries are still making people uneasy, and on top of that you've got politics, plus broad anxiety regarding data centers. So, since you have valuable insight into many of these areas, is there anything you'd like to add that could help us reason through those concerns?
Well, I'd say I'm with you on that. In some ways, the market seems to be viewing us as an AI-focused company, since a meaningful chunk of our business is tied to data centers. But keep in mind, data centers aren't going anywhere, in my view. New technology will keep flowing into them. Technology in data centers gets refreshed roughly every three to four years, right? So the very same technologies headed into AI data centers will also land in ordinary cloud data centers, right? And volume of investment only accounts for part of what drives the data center business. Also, let's not overlook that we've broadened our TAM. We're moving into semiconductor testing as well as testing for fiber optics and connector production. Whether it's an AI data center or a cloud data center replacement, it will still represent a new market. The key factors are the shortening of product cycles and densification—that's what it all comes down to. I'd say only part of data center spending for us—well, a significant part is clearly driven by CapEx—but we still lag considerably behind what has been spent or committed. In terms of what actual demand will be, we remain far behind that curve; and that's just the data center. On top of that, there's aerospace and defense. You might figure there could be a decline in defense budgets, but one thing I can tell you is that spending will rise dramatically on all things autonomous—drones, for example, along with those cheaper weapon systems that need their own embedded PNT. Our position in that market is very strong. And finally, we made a lot of sales between 2020 and 2022. Every one of those products is now quite dated, and we're likely looking at a multi-year—we're getting close to a multi-year replacement and refresh cycle among service providers, and that's sort of the rising tide that lifts every boat. Anyone who views Viavi purely as an AI story is, in my view, badly underestimating how varied our end markets are and the areas we compete in. Wireless will recover at some point too. It's been a significant drag for the last three years. Eventually it becomes a tailwind, and clearly that will kick off another growth phase. I'm feeling reasonably positive about our business. We're not a one-trick pony. We're actually quite well diversified, and multiple technology cycles are moving in our direction, not only AI. Still, AI is plainly a big one.
Yeah, Mike, I might add that during the prepared remarks we made a point of highlighting that we expect continued growth over the next few quarters. That guidance is updated. It hasn't changed because of the political aspect you brought up earlier. I mean, AI isn't going anywhere, and data centers will keep on—
Anyone who believes AI is finished is, frankly, delusional, because the remainder of the globe is still out there—there's a basic competitive dynamic at work. It might not expand quite as fast, but expand it will, and the investment already being put in is quite substantial. That's basically how I see it.
Yeah. Great. Thanks for the feedback — I really appreciate it.
Let me add just one more point: we've never oversold it. I mean, plenty of companies have gotten ahead of themselves. Our take on how it would grow was always more measured and conservative — in fact, we were probably a bit too conservative. We figured we'd reach a $500 million run rate by the end of next calendar year. Then we moved that to the middle of the calendar year, and now it's been pulled forward to the end of this calendar year. So if anything, you could fairly say we were overly conservative on that front. So in a sense, it's playing out as expected.
Thank you. Oleg, on that note regarding AI, I'd like to ask at a broad level: have you noticed any shifts in how your customers are buying — has anyone tweaked spending in certain areas or trimmed back in spots, or does it look largely the same as before?
Well, honestly, in a lot of ways I'd say our expectations were behind actual demand, and if anything, the rise in spending has caught us by surprise more and more. I think we're largely chasing to catch up. As I mentioned just before you joined, we figured we'd reach $500 million by the end of next calendar year, and we ended up pulling that forward by pretty much almost the whole year. I don't see any slowdown, though again, I'd say our outlook was probably much more conservative. If there does turn out to be some pullback, it still gives us upside.
This connects back to what we said earlier as well—we expect that growth will keep continuing over the coming few quarters.
Precisely.
Once more, for us there is no difference at all.
Understood. Ilan, I've got a question about the NSE margin, okay? Like you said before, it was quite strong in Q1 and the guidance for Q2. I'm just curious, is there any leftover Spirent synergy coming through in H1, or does this all stem from scaling the business?
It all stems from scaling the business. The Spirent integration wrapped up at least two, three quarters back. It went pretty quickly and smoothly, and what you're seeing at present is entirely the leverage we get from the growth we're experiencing.
My view is that in this quarter, and even the prior one, what we're seeing are the first products that were, you could say, jointly designed, or perhaps integrated, and likely in the next calendar year we'll bring out offerings that are completely integrated across Spirent and the Viavi portfolio. So in that sense, on the product lines — organizationally, we are completely integrated. As far as the product lines go, I'd say we're already 25% of the way there. Probably as we exit next year, we ought to be beyond 75%.
Understood. So one final question, Oleg, and it's for you. A couple of years back, when I first began covering you folks, my sense was that the market was considerably tighter, margins were significantly lower, and you were a smaller company. You've clearly scaled up through Spirent, and obviously AI and data centers have handed you a great deal of scale along with much improved margins. So I'm curious: as you look at this business, does anything shift in how you think longer term — in terms of where you're putting investment, which markets you're pursuing? One thing I'm especially interested in is that you mention the semiconductor tests and some of the wins you've had in these other markets. I'm wondering whether you're taking more share on the R&D side, whether you're seeing that, and whether that could potentially form part of your strategy going forward.
Well, I think — look, back when you began covering us, we were still heavily weighted toward service provider field instruments. But actually, on gross margin, maybe the low 60s isn't that much lower, though because the company was smaller in size, the R&D and sales burden was much heavier. Consequently, your operating margins came out far below NSE's. What's really driving the operating margin improvement more than anything else is growth on the top line, right? On top of that, when you bring Spirent into the mix, it obviously comes with a higher margin, so that provides a bit of a lift to the overall picture. That said, even taking that into account, Spirent put up solid growth, but it's in the low teens. Our organic business was up about 50% year over year for the September quarter — just Viavi on its own, nothing from acquisitions, right? From that angle, with the products we're shifting toward, it's really just the sales volume — a lot of that flows directly down to the bottom line. When we talk about that growth, I mean, one of the key areas we've been focused on is clearly the R&D test, and that's sort of leading the market. Yet production is really the area with the largest volume increase when it comes to semiconductor test, correct? Obviously, we're present in every lab at every high-performance semiconductor firm as they test PCI Express, 1.6T Ethernet, and similar technologies. Still, in terms of sheer volume, the revenue and unit growth come from production testing. When we refer to production testing, that covers more than just the conventional in-and-out checks on pluggable modules. It now extends to as many as five insertion steps—starting at wafer probe, moving through known good die testing, then optical engine test, then the assembled substrate together with the optical engine, and finally all the way to final test. That final piece is where we're seeing growth, and we began shipping into that market during the first quarter. The second factor is the rising complexity and densification. The industry will shift toward multi-core fiber and toward massive parallel fiber optic connectors. Our equipment is likewise being pulled into the supply chain for producing fiber optics and connectors. This is much more than a typical optical module test. And finally, I'd point to the OCS. We've participated in that market for a long time. Its volumes had been relatively modest, but they're now starting to scale, and we're also seeing considerable demand for our products, fueled by OCS growth.
That's a great call.
Hope that helped.
Many thanks, Oleg, and thank you.
All right, thanks, Andrew.
Good afternoon, and congratulations on the strong results. I'd like to return to what you said about the CPO/NPO opportunity. I believe you mentioned an expectation this could become a business worth more than $100 million. I'm trying to connect that with what your customers are seeing, right? Lumentum just referenced a $5 billion order, which I assume spans several years. How does revenue at that scale map to the opportunity for Viavi? Should we be assuming something like, I don't know, low to mid-single digits — if this is a $2 billion yearly business for your customers, does that mean $100 million for you? And on the other hand, would you make the same statement regarding OCS and its potential to reach $100 million+, as you did for NPO?
When I mention $100 million+, that figure is purely semiconductor. OCS isn't included in it, right? That's more along the lines of your Ethernet switching or AI processor and similar things. OCS is a different animal. In that case, the content per port is fairly substantial, since the time to testing is also considerable. I'd say, well, generally people claim they'll do $2 billion. What I wonder is whether that's an annual run rate, or whether it's across three years, or something else, right? Obviously, from that point, we can-
Well, let's just call it yearly.
whenever they add capacity. Well, I mean, to back that level of support, you'd likely be looking at tens of millions of dollars—perhaps somewhere between $15 million and $100 million.
Wonderful; and what I was merely attempting to get across was-
That's pretty much okay.
When you consider the OCS-
Picture it like a-
No, no.
Yeah. Up to 5%.
That's good.
5% of your revenue.
Great. What I meant was, when we discuss the CPO opportunity, would OCS end up being roughly the same size over time, or larger, given that the two aren't connected?
My view is that CPO with switches and ASICs represents a bigger volume opportunity, since, well, purely in terms of volume, that's a substantially larger business, correct? Because consider this: with OCS, you're essentially reaching the core, so you don't require—now, there's considerable test time involved for every unit, since you might have something like a 300 by 300 switch, yet it sits more or less at the center. If you look at, I mean, when we're discussing CPO with ASICs and CPUs, far more of them sit at the edge, and you require multiple insertions; it's somewhat difficult to say, because I believe there aren't sufficient data points to truly determine how things will play out; however, in that case, you have a far greater volume of ASICs, correct? Unit volumes run considerably higher, and multiple insertions are needed. My bet on it, I'd say, is that it will likely be fairly substantial. Perhaps, yes, I'd put it this way: OCS carries lower volume but greater value per shipment, whereas CPO with ASICs brings much higher volume with lower value per shipment.
Great, thanks. If there's room for one more question. You said organic growth was at 50%. I'm going to take it that data center growth year over year was above that figure, and that it now accounts for over half of NSE revenue. Would you say both of those hold true at this stage?
Yeah. Looking at last year's September quarter against this one, NSE came in at $216 million in September 2026. Sorry, and now it's 25, and then now it's 376. So that's $160 million of growth. Spirent accounts for 52 million of that, so once you back it out, you get roughly $100 million of growth. On data center, yeah, it's clearly above 50%. Aerospace and defense, I'd say, is the next highest, and aerospace and defense plus field instruments are, I'd say, slightly north of 50%, while data center is, well, nearly 2X.
Excellent; I take it we're discussing growth rates in that context. Still, thank you, and congratulations.
Yes, growth rates.
Thanks, Jonathan. That brings today’s earnings call to a close. We appreciate all of you being with us. Enjoy the rest of your afternoon.
This concludes today's call. Thank you for attending. You may now disconnect.
Read the full transcript via the API
You're viewing the first half of this call. Get the complete Viavi Solutions Inc. transcript - plus 133,000+ transcripts from 7,000+ companies, speaker segments and full-text search - through the EarningsAPI REST API or hosted MCP server.
Get an API key View API docs →For developers and AI pipelines
Programmatic access to Viavi Solutions Inc. earnings transcripts and 133,000+ others is available through the
EarningsAPI REST API and the hosted MCP server.
Quarterly plans from $162 - full transcripts, speaker segments, full-text search,
and the /api/v1/transcripts/recent polling endpoint for ETL pipelines.